An analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution

被引:8
|
作者
Horiuchi, Kiyomi [1 ]
Okamoto, Takahiro [1 ]
Iihara, Masatoshi [1 ]
Tsukada, Toshihiko [2 ]
机构
[1] Tokyo Womens Med Univ, Dept Endocrine Surg, Shinjuku Ku, Tokyo 1628666, Japan
[2] Natl Canc Ctr, Res Inst, Tumor Endocrinol Project, Tokyo 104, Japan
关键词
Multiple endocrine neoplasia type 1; Primary hyperparathyroidism; Genotype-phenotype analysis; MEN1; GENE; MUTATIONS; SURGERY; DEATH;
D O I
10.1007/s00595-012-0354-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
To examine the clinical characteristics and survival outcomes of patients with primary hyperparathyroidism (PHPT) in multiple endocrine neoplasia type 1 (MEN1) in relation to the MEN1 gene mutation. The study population included the patients, positive for the MEN1 gene mutation, who underwent parathyroidectomy between 1983 and 2009 at a single tertiary referral center. Manifestations of the syndrome, other tumors and causes of death were retrospectively correlated with the specific types and locations of MEN1 gene mutations. Thirty-two patients from 19 families were diagnosed as having MEN1 on genetic examinations. Mutations were most common in exons 2, 7 and 10. A phenotypic analysis of the main MEN1 tumor types among the 32 patients revealed that PHPT was the most common (100 %), followed in order by pancreatic neuroendocrine tumors (PNETs) (53 %) and pituitary tumors (38 %). Death due to MEN1-related disease occurred in five patients (16 %), including malignant PNET in three cases (exons 2, 3), pituitary crisis in one case (exon 2) and thymic cancer in one case (large deletion). Premature deaths related to MEN1 are due to the development of malignant PNET, pituitary crisis or thymic tumors associated with mutations in exons 2, 3 and a large deletion.
引用
收藏
页码:894 / 899
页数:6
相关论文
共 50 条
  • [41] Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India
    Goroshi, Manjunath
    Bandgar, Tushar
    Lila, Anurag R.
    Jadhav, Swati Sachin
    Khare, Shruti
    Shrikhande, Shailesh V.
    Uchino, Shinya
    Dalvi, Abhay N.
    Shah, Nalini S.
    FAMILIAL CANCER, 2016, 15 (04) : 617 - 624
  • [42] Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype Is There Any Advance on Predicting or Preventing?
    Ramamoorthy, Bhavishya
    Nilubol, Naris
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (02) : 315 - 325
  • [43] Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report
    Tan, Jie
    Zhang, Yuzhi
    Han, Xue
    Fan, Yaofu
    Xu, Juan
    Chen, Guofang
    Liu, Chao
    Xu, Shuhang
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2024, 41 (01)
  • [44] Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure
    Nilubol, Naris
    Weinstein, Lee S.
    Simonds, William F.
    Jensen, Robert T.
    Marx, Stephen J.
    Kebebew, Electron
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (02) : 416 - 423
  • [45] Germline mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in a family with primary hyperparathyroidism
    Ohye, H
    Sato, M
    Matsubara, S
    Miyauchi, A
    Imachi, H
    Murao, K
    Takahara, J
    ENDOCRINE JOURNAL, 1998, 45 (06) : 719 - 723
  • [46] A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1
    Lairmore, Terry C.
    Govednik, Cara M.
    Quinn, Courtney E.
    Sigmond, Benjamin R.
    Lee, Cortney Y.
    Jupiter, Daniel C.
    SURGERY, 2014, 156 (06) : 1326 - 1335
  • [47] Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center
    de Menezes Montenegro, Fabio Luiz
    Lourenco Junior, Delmar Muniz
    Tavares, Marcos Roberto
    Arap, Sergio Samir
    Nascimento Junior, Climerio Pereira
    Massoni Neto, Ledo Mazzei
    D'Alessandro, Andre
    Toledo, Rodrigo Almeida
    Coutinho, Flavia Lima
    Brandao, Lenine Garcia
    de Britto e Silva Filho, Gilberto
    Cordeiro, Anoi Castro
    Almeida Toledo, Sergio Pereira
    CLINICS, 2012, 67 : 131 - 139
  • [48] Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis
    Bouriez, Damien
    Gronnier, Caroline
    Haissaguerre, Magalie
    Tabarin, Antoine
    Najah, Haythem
    WORLD JOURNAL OF SURGERY, 2022, 46 (11) : 2666 - 2675
  • [49] Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing's syndrome accompanied by hyperglycemia: a case report
    Kubo, Haremaru
    Wada, Ryota
    Sekikawa, Naohiro
    Nomura, Yasuhisa
    Yamada, Mutsuo
    Inoue, Minoru
    Hattori, Naoki
    Yamazaki, Yuto
    Sugimoto, Kazuhiro
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [50] No evidence of adverse fertility and pregnancy outcomes in patients with unrecognized and untreated multiple endocrine neoplasia type 1
    Thompson, Michael
    Burgess, John
    CLINICAL ENDOCRINOLOGY, 2019, 90 (02) : 312 - 319